Results 271 to 280 of about 488,312 (382)
IgE based therapeutics are an emerging modality in cancer treatment. [PDF]
Kumari S, Ghosh S, Doerner A.
europepmc +1 more source
Human IgE-independent systemic anaphylaxis.
F. Finkelman, M. Khodoun, R. Strait
semanticscholar +1 more source
The alpha and beta diversity of the nasal microbiome differed among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls (HCs). Compared to HC, AR had more Escherichia‐Shigella, Negativicoccus, and Campylobacter, while NAR had more Dolosigranulum and fewer Enterobacteriaceae.
Kantima Kanchanapoomi +6 more
wiley +1 more source
The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism. [PDF]
Cheng L, Sun L.
europepmc +1 more source
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source
IgE and mast cells in host defense against parasites and venoms
K. Mukai +4 more
semanticscholar +1 more source
ABSTRACT Accurate diagnosis is essential for timely intervention in atopic dermatitis (AD), yet delays in diagnosis remain common. To better understand current clinical practices regarding infantile AD, a questionnaire survey was conducted among Japanese pediatricians working at medical institutions with 19 or fewer beds.
Kiwako Yamamoto‐Hanada +6 more
wiley +1 more source

